VEGF-A leads to arteriolar dilatation, increased blood flow, disrupted endothelial barrier, microaneurysm formation, increased vascular permeability, and neovascularization [2]. Patients with diabetic retinopathy (DR) have increased levels of VEGF-A in serum and vitreous [3,4]. This evidence concerns the gene VEGFA and diabetic retinopathy.